Related Experiment Video
Updated: Apr 16, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the
P Wimmer1, J Berscheminski1, P Blanchette2
1Department of Viral Transformation, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Abstract:
Although modulation of the cellular tumor-suppressor p53 is considered to have the major role in E1A/E1B-55K-mediated tumorigenesis, other promyelocytic leukemia nuclear body (PML-NB)/PML oncogenic domain (POD)-associated factors including SUMO, Mre11, Daxx, as well as the integrity of these nuclear bodies contribute to the transformation process. However, the biochemical consequences and oncogenic alterations of PML-associated E1B-55K by SUMO-dependent PML-IV and PML-V interaction have so far remained elusive. We performed mutational analysis to define a PML interaction motif within the E1B-55K polypeptide. Our results showed that E1B-55K/PML binding is not required for p53, Mre11 and Daxx interaction. We also observed that E1B-55K lacking subnuclear PML localization because of either PML-IV or PML-V-binding deficiency was no longer capable of mediating E1B-55K-dependent SUMOylation of p53, inhibition of p53-mediated transactivation or efficiently transforming primary rodent cells. These results together with the observation that E1B-55K-dependent SUMOylation of p53 is required for efficient cell transformation, provides evidence for the idea that the SUMO ligase activity of the E1B-55K viral oncoprotein is intimately linked to its growth-promoting oncogenic activities.
Insights
The E1B-55K viral oncoprotein
Area of Science:
- Oncogenic mechanisms
- Viral oncogenesis
- Cellular transformation
Background:
- Cellular tumor suppressor p53 modulation is key in E1A/E1B-55K tumorigenesis.
- Promyelocytic leukemia nuclear body (PML-NB)/PML oncogenic domain (POD) factors contribute to cell transformation.
- Biochemical consequences of E1B-55K interaction with SUMO-dependent PML-IV and PML-V remain unclear.
Purpose of the Study:
- To investigate the role of E1B-55K/PML interaction in tumorigenesis.
- To elucidate the biochemical consequences of SUMO-dependent PML-IV and PML-V interaction with E1B-55K.
- To define the PML interaction motif within E1B-55K.
Main Methods:
- Mutational analysis of E1B-55K to define PML interaction motif.
- Assessment of E1B-55K binding to PML.
- Evaluation of E1B-55K's effect on p53 SUMOylation and transactivation.
- Testing the oncogenic transformation potential of E1B-55K mutants.
Main Results:
- E1B-55K/PML binding is not essential for interaction with p53, Mre11, or Daxx.
- E1B-55K mutants deficient in PML localization lost the ability to SUMOylate p53.
- These mutants also failed to inhibit p53 transactivation and efficiently transform cells.
- E1B-55K-dependent p53 SUMOylation is crucial for efficient cell transformation.
Conclusions:
- E1B-55K's SUMO ligase activity is intrinsically linked to its growth-promoting oncogenic functions.
- PML localization is critical for E1B-55K's oncogenic activities.
- The study highlights the importance of PML-NB integrity in viral oncogenesis.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
10:22Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Inhibitors of Viral Protein Synthesis